Patients, caregivers, and family members are invited to join United Therapeutics and the Pulmonary Fibrosis Foundation (PFF) for an industry hosted webinar at 1:30 p.m. CT on Wednesday, December 13. This presentation will focus on how a patient is diagnosed with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Presenters will discuss the tests that are performed at diagnosis.
This is the second webinar in the Industry Hosted webinar series. Even if you were unable to join the first webinar on October 31, which defined PH-ILD, discussed how ILD progresses to PH-ILD, and reviewed symptoms of PH-ILD that patients may experience, we encourage you to attend this webinar!
Dr. Hyun Kim
Director of the Interstitial Lung Disease Program and Associate Professor of Medicine at the University of Minnesota Medical School
Dr. Thenappan Thenappan
Associate Professor of Medicine, Cardiology at the University of Minnesota Medical School
Moderated by: Dr. Amy Hajari Case
Senior Medical Advisor of Education and Awareness at the PFF and Director of the Interstitial Lung Disease Program and Pulmonary and Critical Care Research Department at Piedmont Healthcare
This Industry Hosted Webinar is supported by United Therapeutics. Opinions expressed and resources shared may not have been reviewed by the PFF before distribution through PFF channels, or reflect official positions of the PFF unless it is explicitly noted as a result of official PFF approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the PFF unless it is explicitly noted as a result of official PFF approval.